Trials / Completed
CompletedNCT02163122
Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)
A Pilot Study to Compare Responses to Cat Allergen Exposure Using the Environmental Exposure Chamber (EEC) and Nasal Allergen Challenge (NAC)
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID) · NIH
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot trial in cat allergic participants, designed to compare allergic responses in each participant to a specific allergen by two methods of exposure. The methods of exposure to be used are: the environment exposure chamber (EEC) and nasal allergen challenge (NAC). Potential participants will be screened for evidence of cat allergy. Participants with a range of allergic sensitivities to cat allergen will be enrolled. To help ensure some breadth in the level of allergic sensitivity among participants, individuals with both high and low exposures to cat allergens in their daily lives will be enrolled.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Nasal Allergen Challenge | Cat allergen (FelD1) applied directly to the nasal tissues |
| OTHER | Environmental Exposure Chamber | The mobile EEC (mEEC) is a movable facility, designed with clean-room technology, used to expose subjects to aeroallergens (in this trial, the allergen FelD1 from cats) at controlled, consistent airborne levels, similar to that experienced in subjects' daily lives. |
| BIOLOGICAL | Cat allergen (FelD1) |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2014-06-13
- Last updated
- 2017-09-12
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02163122. Inclusion in this directory is not an endorsement.